The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Apr 2022 14:46

RNS Number : 3104I
CATCo Reinsurance Opps Fund Ltd
13 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

BMG1961Q5064

Issuer Name

CATCO REINSURANCE OPPORTUNITIES FUND LTD.

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Baillie Gifford & Co

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

11-Apr-2022

6. Date on which Issuer notified

13-Apr-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

0.000000

0.000000

0

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

Ordinary Share BMG1961Q4075

0

0.000000

C Shares BMG1961Q5064

0

0.000000

Sub Total 8.A

0

0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Baillie Gifford & Co

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

13-Apr-2022

13. Place Of Completion

Edinburgh

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUOSORUNUSAAR
Date   Source Headline
24th May 20064:36 pmRNSRule 8.3- Cambrdige Antibody
24th May 20064:24 pmRNSEPT Disclosure
24th May 20063:55 pmRNSRule 8.3- Cambridge Antibody
24th May 20063:35 pmRNSHolding(s) in Company
24th May 20063:20 pmRNSHolding(s) in Company
24th May 20061:40 pmRNSHolding(s) in Company
24th May 200612:16 pmRNSEPT Disclosure
24th May 200611:46 amRNSEPT Disclosure
24th May 200610:11 amRNSRule 8.3- Cambridge Antibody
24th May 20067:02 amRNSRule 8.1- Cambridge Antibody
23rd May 20066:07 pmRNSMarket Maker Holding
23rd May 20065:01 pmRNSEPT Disclosure
23rd May 20064:29 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:35 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:17 pmRNSRule 8.3- Cambridge Antibody
23rd May 200611:46 amRNSEPT Disclosure
23rd May 200611:46 amRNSRule 8.3- Cambridge Antibody
23rd May 200611:42 amRNSEPT Disclosure
23rd May 20067:01 amRNSAstraZeneca Offer for CAT
22nd May 20062:40 pmRNSRule 8.3- Cambridge Antibody
22nd May 20062:37 pmRNSRule 8.3- Cambridge Antibody
22nd May 200612:31 pmRNSEPT Disclosure
22nd May 200611:52 amRNSEPT Disclosure
22nd May 200611:41 amRNSEPT Disclosure
22nd May 20067:01 amRNSInterim Results
19th May 20065:41 pmRNSRule 8.3- Cambridge Antibody
19th May 20064:46 pmRNSEPT Disclosure
19th May 200612:49 pmRNSEPT Disclosure
19th May 200612:16 pmRNSEPT Disclosure
18th May 20065:08 pmRNSEPT Disclosure - Amendment
18th May 20065:05 pmRNSHolding(s) in Company
18th May 20064:28 pmRNSHolding(s) in Company
18th May 20064:27 pmRNSHolding(s) in Company
18th May 20064:25 pmRNSHolding(s) in Company
18th May 20064:00 pmRNSEPT Disclosure
18th May 20063:03 pmRNSRule 8.3- Cambridge Antibody
18th May 200611:44 amRNSEPT Disclosure
18th May 200611:21 amRNSNotice of Results
18th May 200611:08 amRNSEPT Disclosure
18th May 200610:54 amRNSHolding(s) in Company
18th May 20067:00 amRNSMarket Maker Holding
17th May 20063:46 pmRNSRule 8.3- Cambridge Antibody
17th May 20062:55 pmRNSEPT Disclosure - Amendment
17th May 200612:31 pmRNSEPT Disclosure
17th May 200612:28 pmRNSEPT Disclosure
17th May 200611:20 amRNSEPT Disclosure
17th May 200611:00 amRNSMerger Update
17th May 200610:31 amRNSRule 8.3- Cambridge Antibody
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.